Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
26
Number of overlapping holdings
19.1%
% of XBI's 136 holdings also in CANC
55.3%
% of CANC's 47 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
INCYTE CORP | 2.9% | 4.2% | 2.9% |
|
GILEAD SCIENCES INC | 2.8% | 5.4% | 2.8% |
|
EXACT SCIENCES CORP | 2.4% | 1.7% | 1.7% |
|
BLUEPRINT MEDICINES CORP. | 1.7% | 4.3% | 1.7% |
|
REGENERON PHARMACEUTICALS | 1.6% | 5.4% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CANC
|
NATERA INC | 3.3% |
|
UNITED THERAPEUTICS CORP | 2.7% |
|
SAREPTA THERAPEUTICS INC | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
INSMED INC | 2.5% |
|
ADVENTRX PHARMACEUTICALS INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
|
ALNYLAM PHARMACEUTICALS INC | 2.4% |
|
ABBVIE INC | 2.4% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.2% |
XBI Underweight Relative to CANC
 |
ASTRAZENECA PLC | -5.2% |
 |
ARGENX SE ADR | -4.3% |
|
ILLUMINA INC | -3.8% |
|
REGENERON PHARMACEUTICALS | -3.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
REVOLUTION MEDICINES, INC. | -3.1% |
|
DAIICHI SANKYO CO LTD | -3.1% |
|
MERCK & CO. INC. | -2.9% |
|
BLUEPRINT MEDICINES CORP. | -2.7% |
|
GILEAD SCIENCES INC | -2.6% |